WHO lowers number of suspected Ebola cases

Date:

Share this article:

Del denne artikel:

The World Health Organization (WHO) has reduced the number of possible Ebola cases in the Democratic Republic of Congo following new assessments and testing.

It has been difficult to gain a clear picture of the Ebola outbreak in the Democratic Republic of Congo.

According to Reuters, as reported by DR, this is partly because the most commonly used test did not detect the Bundibugyo strain responsible for the current outbreak.

As a result, some people were initially registered as possible cases without confirmation that they were infected with Ebola.

Cases under investigation

WHO stated, according to DR, that the figures may still change as more people are tested.

Also read: Overlooked organ linked to longer life and lower disease risk

Reuters reports that individuals who had contact with infected persons or showed symptoms of Ebola were automatically classified as suspected cases.

While this approach provided authorities with a broad overview of the situation, it also means that some individuals may later be removed from the case count.

Number revised downward

On Friday, WHO reported 906 suspected Ebola cases in the Democratic Republic of Congo.

Reuters now reports that the organization estimates the number at 116.

Also read: Forget the protein bar: These snacks provide both protein and fibre

The reason is that many of the registered individuals were found to have other illnesses or experienced only short-term fever.

As a result, the outbreak now appears to be less widespread than initially believed.

Sources: DR, Reuters, and WHO.

Also read: This much exercise can reduce the risk of inherited heart disease

Also read: Experts say millions are choosing the wrong drink for energy

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Creatinine levels by age and sex: what your blood test number means

The lab number most people see first tells only half the kidney story.

How eating ginger every day can affect your blood pressure and joints

A new NIH-listed meta-analysis puts a number on the daily-ginger habit.

GLP-1 drugs like Ozempic may now be an option for a group of patients long left out

The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.

Your gut bacteria may spread to the people around you more easily than anyone realized

A new Nature study finds gut microbes spread between people, sometimes across continents, faster than expected.

Creatinine levels by age and sex: what your blood test number means

The lab number most people see first tells only half the kidney story.

How eating ginger every day can affect your blood pressure and joints

A new NIH-listed meta-analysis puts a number on the daily-ginger habit.

GLP-1 drugs like Ozempic may now be an option for a group of patients long left out

The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.